Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 99
Evodiamine alleviates DEHP-induced hepatocyte pyroptosis, necroptosis and immunosuppression in grass carp through ROS-regulated TLR4 / MyD88 / NF-κB pathway
Yutian Lei, Tong Xu, Wenying Sun, et al.
Fish & Shellfish Immunology (2023) Vol. 140, pp. 108995-108995
Closed Access | Times Cited: 47
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
Carlo Airola, Andrea Severino, Serena Porcari, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 868-868
Open Access | Times Cited: 27
Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer
Tuoyu Zhou, Jingyuan Wu, Haibo Tang, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Role of Dietary Defatted Rice Bran in the Modulation of Gut Microbiota in AOM/DSS-Induced Colitis-Associated Colorectal Cancer Rat Model
Laleewan Tajasuwan, Aikkarach Kettawan, Thanaporn Rungruang, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1528-1528
Open Access | Times Cited: 19
Gut Microbiota and Inflammation Modulation in a Rat Model for Ulcerative Colitis after the Intraperitoneal Administration of Apigenin, Luteolin, and Xanthohumol
Patricia Magadán‐Corpas, Álvaro Pérez‐Valero, Suhui Ye, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3236-3236
Open Access | Times Cited: 7
Sishen Pill and its active phytochemicals in treating inflammatory bowel disease and colon cancer: an overview
Boxun Zhang, Yingying Cheng, Jian Qin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway
Dongjin Pan, Bingyao Huang, Yuman Gan, et al.
Marine Drugs (2022) Vol. 20, Iss. 4, pp. 260-260
Open Access | Times Cited: 27
Exposure to chlorinated drinking water alters the murine fecal microbiota
Jana Jandová, Gabriele Schiro, Frank A. Duca, et al.
The Science of The Total Environment (2024) Vol. 914, pp. 169933-169933
Open Access | Times Cited: 5
Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer
Mengxia Wang, Yan Ma, Guodong Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117292-117292
Open Access | Times Cited: 5
Environmentally-Relevant Concentrations of Atrazine Had Minor Impacts on Gut Microbiota and Liver Metabolite in Juvenile Turtles
Huo-Bin Tang, Xin-Ru Qian, Wanqiu Yang, et al.
Archives of Environmental Contamination and Toxicology (2025)
Closed Access
The intervention of NLRP3 inflammasome inhibitor: oridonin against azoxymethane and dextran sulfate sodium–induced colitis-associated colorectal cancer in male BALB/c mice
Gurpreet Kaur, Priyanka Tiwari, Shivani Singla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022
Facheng Bai, Zhenguang Huang, Jun Luo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Research status of indole-modified natural products
Song-Fang Duan, Lei Song, Hongyan Guo, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2535-2563
Closed Access | Times Cited: 11
Sexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies
Yair Rodríguez-Santiago, Claudia Angélica Garay-Canales, Karen Elizabeth Nava‐Castro, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Natural Products and Derivatives Targeting Metabolic Reprogramming in Colorectal Cancer: A Comprehensive Review
Mengyu Wang, Liqun Qu, Xinying Du, et al.
Metabolites (2024) Vol. 14, Iss. 9, pp. 490-490
Open Access | Times Cited: 4
Chaihuang Qingyi Huoxue granule ameliorates severe acute pancreatitis by modulating gut microbiota and repairing the intestinal mucosal barrier
Xiaobin Zhang, Xiaoqun Zeng, Wen Guo, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Pterostilbene Exhibited the Anticancer Effect Against 1, 2‐Dimethylhydrazine (DMH)‐Induced Colorectal Cancer via Alteration of Oxidative Stress, Inflammation and Gut Microbiota
Chang Guo, Ankit Kumar, Liao Chao
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Network Pharmacology and Experimental Validation Reveal Sishen Pill’s Efficacy in Treating NSAID-Induced Small Intestinal Ulcers
Jiangtao Zhou, Fengting Zhu, Hong Liang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 2035-2050
Open Access
Quinoxalinone substituted pyrrolizine (4h)-induced dual inhibition of AKT and ERK instigates apoptosis in breast and colorectal cancer by modulating mitochondrial membrane potential
Tanzeeba Amin, Rajneesh Paul Sharma, Khalid Bashir Mir, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175945-175945
Closed Access | Times Cited: 9
Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis
Laura Hidalgo‐Garcia, Antonio Jesús Ruiz‐Malagón, Francisco Huertas, et al.
Pharmacological Research (2023) Vol. 195, pp. 106891-106891
Open Access | Times Cited: 9
From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine
Yanan Yang, Jiaguo Zhan, Ying Cao, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 4, pp. 413-444
Closed Access | Times Cited: 3
The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: A review
Shubin Fu, Liying Liao, Yi Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents
Jiedan Deng, Lin Long, Peng Xue, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115366-115366
Closed Access | Times Cited: 8
The crosstalk between intestinal microbiota and MDSCs fuels colitis associated cancer development
Hadas Ashkenazi‐Preiser, Or Reuven, Atara Uzan-Yulzari, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1063-1081
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top